Found: 6
Select item for more details and to access through your institution.
EFICÁCIA SUPERIOR DE DOLUTEGRAVIR (DTG) MAIS 2 INIBIDORES DA TRANSCRIPTASE REVERSA (ITRNS) COMPARADA COM LOPINAVIR/R MAIS 2 ITRNS NA SEGUNDA LINHA DE TRATAMENTO – DADOS DE 48 SEMANAS DO ESTUDO DAWNING.
- Published in:
- Brazilian Journal of Infectious Diseases, 2018, v. 22, p. 56, doi. 10.1016/j.bjid.2018.10.105
- By:
- Publication type:
- Article
SEGURANÇA E EFICÁCIA DA TERAPIA ANTIRRETROVIRAL BASEADA EM DOLUTEGRAVIR, NA SEMANA 48, EM ADULTOS COINFECTADOS HIV/TB.
- Published in:
- Brazilian Journal of Infectious Diseases, 2018, v. 22, p. 14, doi. 10.1016/j.bjid.2018.10.027
- By:
- Publication type:
- Article
Efficacy of second-line dolutegravir plus 2 nucleoside reverse transcriptase inhibitors by baseline nucleoside reverse transcriptase inhibitor resistance and nucleoside reverse transcriptase inhibitor use in the DAWNING study.
- Published in:
- Antiviral Therapy, 2022, v. 27, n. 1, p. 1, doi. 10.1177/13596535221077487
- By:
- Publication type:
- Article
Efficacy of second-line dolutegravir plus 2 nucleoside reverse transcriptase inhibitors by baseline nucleoside reverse transcriptase inhibitor resistance and nucleoside reverse transcriptase inhibitor use in the DAWNING study.
- Published in:
- Antiviral Therapy, 2022, v. 27, n. 2, p. 1, doi. 10.1177/13596535221077487
- By:
- Publication type:
- Article
Dolutegravir-based Antiretroviral Therapy for Patients Coinfected With Tuberculosis and Human Immunodeficiency Virus: A Multicenter, Noncomparative, Open-label, Randomized Trial.
- Published in:
- Clinical Infectious Diseases, 2020, v. 70, n. 4, p. 549, doi. 10.1093/cid/ciz256
- By:
- Publication type:
- Article
A retrospective clinical audit of general practices in Australia to determine the motivation for switch to dolutegravir/abacavir/lamivudine and clinical outcomes.
- Published in:
- 2018
- By:
- Publication type:
- journal article